Search results
Cerity Partners LLC Acquires New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
ETF DAILY NEWS· 23 hours agoCerity Partners LLC purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the 4th quarter, according ...
Teva's Revive Collections Travels Back to the 2000s, Photos
Footwear News via Yahoo News· 1 day agoCelebrating its 40th anniversary and giving continuity to its Revive Collections, Teva has launched...
Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
GuruFocus.com via Yahoo Finance· 2 hours agoNegative Points Corcept Therapeutics Inc faces significant legal challenges, including a recent court ruling allowing Teva Pharmaceuticals to market a generic version of Korlym ...
Generic Drug Giant Teva Hires New Legal Chief After DOJ Deal
Bloomberg Law· 1 day agoTeva Pharmaceutical Industries Ltd. has a new chief legal officer in David McAvoy, who succeeds David Stark as the top lawyer for the world’s largest generic drug manufacturer.
Spring Has Sprung Obviousness Trends from the Federal Circuit
The National Law Review· 16 hours agoAt the beginning of the month, in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc....
21 best sandals for walking all day long, according to podiatrists
CNN via Yahoo News· 2 days ago“It still looks nice but provides a bit more comfort for more active outings. I wear mostly whites,...
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
Reuters· 10 hours ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the ...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 23 hours agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 3 days agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
Brian Rubenstein
The National Law Review· 5 days agoBrian Rubenstein has a broad range of experience defending pharmaceutical and other companies in a range of large-scale, complex matters. Prior to joining Greenberg Traurig, Brian was with & ...
